Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer
Kaiyang Zhang, Essi Kahelin, Giovanni Marchi, et al.
Frontiers in Oncology
|
September 9, 2022
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
Pia Roering, Arafat Siddiqui, Vanina D Heuser, et al.
Cancer Discovery
|
July 30, 2025
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer
Giulia Micoli, Kari Lavikka, Yilin Li, et al.
Science Advances
|
February 23, 2022
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
Kaiyang Zhang, Erdogan Pekcan Erkan, Sanaz Jamalzadeh, et al.
Briefings in Bioinformatics
|
August 3, 2021
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
Liye He, Daria Bulanova, Jaana Oikkonen, et al.
NPJ Precision Oncology
|
December 29, 2022
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
Fernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, et al.
Cancer Research
|
January 30, 2021
Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in <i>TP53-</i> and <i>BRCA1</i>-Deficient Cells
Anniina Färkkilä, Alfredo Rodríguez, Jaana Oikkonen, et al.
Cancer Cell
|
May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Cancer Discovery
|
November 7, 2020
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy
Sonia Iyer, Shuang Zhang, Simge Yucel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer
Kaiyang Zhang, Essi Kahelin, Giovanni Marchi, et al.
Frontiers in Oncology
|
September 9, 2022
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
Pia Roering, Arafat Siddiqui, Vanina D Heuser, et al.
Cancer Discovery
|
July 30, 2025
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer
Giulia Micoli, Kari Lavikka, Yilin Li, et al.
Science Advances
|
February 23, 2022
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
Kaiyang Zhang, Erdogan Pekcan Erkan, Sanaz Jamalzadeh, et al.
Briefings in Bioinformatics
|
August 3, 2021
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
Liye He, Daria Bulanova, Jaana Oikkonen, et al.
NPJ Precision Oncology
|
December 29, 2022
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
Fernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, et al.
Cancer Research
|
January 30, 2021
Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in <i>TP53-</i> and <i>BRCA1</i>-Deficient Cells
Anniina Färkkilä, Alfredo Rodríguez, Jaana Oikkonen, et al.
Cancer Cell
|
May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Cancer Discovery
|
November 7, 2020
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy
Sonia Iyer, Shuang Zhang, Simge Yucel, et al.
Page
of 4